ArticleJournal for immunotherapy of cancer2022

Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells.

Talar Tokatlian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.